Ponoi Capital II, LP, 10% Owner at RAPT Therapeutics, Inc. (RAPT), sold 16,739 shares at $34.48 ($578K) on 2021-09-27, disclosed to the SEC on 2021-09-29.
Open-market sale of $578k RAPT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.48 | 7,500 | $259K | 44.7% |
| 2 | $34.48 | 7,500 | $259K | 44.7% |
| 3 | $34.94 | 625 | $22K | 3.8% |
| 4 | $34.97 | 1,114 | $39K | 6.7% |
| Total | $34.53 avg | 16,739 | $578K | 100% |
| Filing → |
| NGM | BUY | 2022-10-27 | $1.2M | — | Filing → |
| NGM | BUY | 2022-05-17 | $842K | — | Filing → |
| NGM | BUY | 2020-03-25 | $7.1M | — | Filing → |